Skip to main content

Option Care Health to Participate in the Bank of America Merrill Lynch 2019 Leveraged Finance Conference

Written by Customer Service on . Posted in Public Companies.

BANNOCKBURN, Ill., Nov. 21, 2019 (GLOBE NEWSWIRE) — Option Care Health Inc. (NASDAQ: BIOS), the nation’s largest independent provider of home and alternate treatment site infusion therapy services, will present at the Bank of America Merrill Lynch 2019 Leveraged Finance Conference on December 3, 2019. Mike Shapiro, Option Care Health’s Chief Financial Officer, is scheduled to present at 10:50 a.m. ET. A live audio webcast and replay of this presentation will be available at https://investors.optioncarehealth.com.
About Option Care HealthOption Care Health, Inc. (Option Care Health) (NASDAQ: BIOS), is the nation’s largest independent provider of home and alternate site infusion services. With over 6,000 teammates including 2,900 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and employees. To learn more, please visit our website at OptionCareHealth.com.For Investor Inquiries:
Bob East, Asher Dewhurst, Jordan Kohnstam
Westwicke
443-213-0500
optioncarehealth@westwicke.comFor Media Inquiries:
Jonathan Durrbeck
312-558-1770
JDurrbeck@pcipr.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.